"What is important to note, however, is that this committee worked through the issues in a bipartisan manner, and I am proud of the consensus that we reached."
"The only problem that I have though, now we have this FDA funding bill that the House Republicans just passed, and that guts the FDA's funding by $570 million."
"I appreciate the need for the kinds of proposals listed under the heading of Advancing Regulatory Science and Innovation."
"I think it is going to be very difficult to do any of these new innovations if we see a 21 percent cut."
"America's competitiveness depends on our ability to innovate and keep America number one, and as such I continue to believe that the government must be responsible for facilitating an environment wher..."
"I hope we can move in the same bipartisan spirit as we did in 2007."
"This really shows that we are being bipartisan today."
"I would like to close by commenting on the importance of the Drug Safety Enhancement Act."
"We must not sacrifice safety and efficacy in exchange for innovation."
"We mustn't set a price tag on their care nor should we shape policy with the goal of only saving money."
"The reality is that dual eligibles are a vulnerable population. Their care is both costly and frequently uncoordinated."